Belantamab Biosimilar - Research Grade

In stock
Only %1 left
SKU
ICH5011
Add to Compare
$306.00

Belantamab Biosimilar - Research Grade

More Information
Product Specific Citations

Giang, K.A. et al. An Anti-BCMA Affibody Affinity Protein for Therapeutic and Diagnostic Use in Multiple Myeloma. Int. J. Mol. Sci. 2025, 26, 5186. https://doi.org/10.3390/ijms26115186

Concentration 5mg/ml
Isotype Human IgG1
Host CHO cells
Use Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Application Notes This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Applications Functional Assays
Storage This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Endotoxin ≤ 1.0 EU/mg as determined by the LAL method
Purity >95% by SDS-PAGE
Formulation Sterile, preservative-free, solution in PBS. BSA and Azide free.
Purification Method This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Specificity Detects human BCMA. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Belantamab mafodotin.
Species Reactivity Human
Target BCMA
Shipping Conditions Blue ice
background RUO belantamab mafodotin. Belantamab mafodotin is a medication for the treatment of relapsed and refractory multiple myeloma.
Other names GSK2857916, B-cell maturation antigen, CD269
UniProt Q02223
Buffer ICH3002
Sequence https://www.imgt.org/mAb-DB/
Product Details:

ichorbio's belantamab biosimilar is for Research Use Only (RUO)

Size:

ichorbio's RUO belantamab biosimilar is available in the following sizes: 1mg, 5mg, 10mg, 20mg, 50mg, 100mg ichorbio regularly manufactures bulk multi-gram amounts of this biosimilar - please contact us for pricing.

Isotype Control:

Bulk Human IgG1 Isotype Control (IB1) [ICH2254]

Write Your Own Review
You're reviewing:Belantamab Biosimilar - Research Grade
Your Rating
Back to Top